scispace - formally typeset
C

C. Navarro-San Francisco

Researcher at Carlos III Health Institute

Publications -  4
Citations -  477

C. Navarro-San Francisco is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Retrospective cohort study & Predictive value of tests. The author has an hindex of 3, co-authored 4 publications receiving 338 citations.

Papers
More filters
Journal ArticleDOI

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez-Gutiérrez, +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.
Journal ArticleDOI

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez-Gutiérrez, +86 more
TL;DR: A validated score predictive of early mortality in patients with BSIs due to CPE was developed and exhibited an area under the receiver operating characteristic curve.
Journal ArticleDOI

Direct antimicrobial susceptibility testing from the blood culture pellet obtained for MALDI-TOF identification of Enterobacterales and Pseudomonas aeruginosa

TL;DR: Direct use of the blood culture pellet permits fast AST in bacteremia of Enterobacterales, enabling the clinicians to perform an early treatment adjustment, however, for Pseudomonas aeruginosa, the data needs expanding to improve the reliability of this technique.
Journal ArticleDOI

Forty years of Tuberculous meningitis: The new face of an old enemy

TL;DR: The profile of patients being diagnosed with TBM has changed from a young HIV-infected patient with a history of drug addiction to an elderly patient with non-HIV immunosuppression, which could help explain the increase in mortality observed across the two periods.